Drugdrug interactions were also evaluated near the expected time of maximum semaglutide concentration at steady state
The STEP (Semaglutide Treatment Effect in People with Obesity) trials were a series of global, randomized, controlled clinical trials that It investigated the efficacy and safety of subcutaneous semaglutide in individuals with obesity or overweight without diabetes
In the SURMOUNT-1 trial, tirzepatide at the highest dose (15 mg) produced average weight loss of 22.5% versus approximately 15% for semaglutide in comparable trials
Injection sites Semaglutide injections can be administered in the upper arm, thigh, or stomach
healthcare provider who determines if treatment is appropriate
Consultations with Medical Practitioners Before you can even think about getting a prescription for weight loss injections, you'll need to consult with a medical practitioner